Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease

Journal of AAPOS

Volumn 13, Issue 1, 2009, Pages 94-96

  Çakir, Mehmet ^a   Çekiç, Osman ^a   Yilmaz, Ö Faruk ^a  

^a Beyoglu Eye Research and Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; TRIAMCINOLONE;

ARTICLE; CASE REPORT; CHILD; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAOCULAR PRESSURE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REMISSION; RETINA FOVEA; RETINA HEMORRHAGE; RETINA MACULA VITELLIFORM DEGENERATION; SCHOOL CHILD; SINGLE DRUG DOSE; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CHILD; CHOROIDAL NEOVASCULARIZATION; CORNEAL DYSTROPHIES, HEREDITARY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE; VITREOUS BODY;

EID: 60249086822     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2008.06.014     Document Type: Article

References (9)

1. Hartnett M.E., Trese M., Capone Jr. A., Keats B.J.B., and Steidl S.M. Pediatric retina (2005), Lippincott Williams & Wilkins, Philadelphia (PA) 102-103
2. Deutman A.F., Hoyng C.B., and van Lith-Verhoeven J.J.C. Macular dystrophies/vitelliform dystrophy. In: Ryan S.J., and Schachat A.P. (Eds). Retina: Volume II-Medical Retina (2006), Elsevier Mosby, St. Louis (MO) 1177-1181
3. Sears J., Capone Jr. A., Aaberg Sr. T., Lewis H., Grossniklaus H., Sternberg Jr. P., and De Juan E. Surgical management of subfoveal neovascularization in children. Ophthalmology 106 (1999) 920-924
4. Andrade R.E., Farah M.E., and Costa R.A. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Best disease. Am J Ophthalmol 136 (2003) 1179-1181
5. Nobrega M., Bortolotto C., and Farah M. Combined photodynamic therapy and intravitreal triamcinolone injection for choroidal neovascularization in Best disease. Can J Ophthalmol 42 (2007) 761-762
6. Leu J., Schrage N.F., and Degenring R.F. Choroidal neovascularization secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab. Graefe's Arch Clin Exp Ophthalmol 245 (2007) 1723-1725
7. Çaki{dotless}r M., Çekiç O., and Yi{dotless}lmaz ÖF. Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease. J AAPOS 12 (2008) 309-311
8. Kaiser P.K., Blodi B.A., Shapiro H., Acharya N.R., and MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114 (2007) 1868-1875
9. Kaiser P.K., Brown D.M., Zhang K., Hudson H.L., Holz F.G., Shapiro H., Schneider S., and Acharya N.R. Ranibizumab for predominantly classic neovascular age-related macular degeneration subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 144 (2007) 850-857